# Bionpharma Inc.: Form D filings

Bionpharma Inc., a pharmaceuticals company in Princeton, NJ, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on December 15, 2015, reports $6.5 million sold of a $6.5 million offering to 1 investor.

Find out what Bionpharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Bionpharma%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Bionpharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbionpharma-inc-1624663)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Bionpharma%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Bionpharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbionpharma-inc-1624663)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 600 ALEXANDER ROAD, SUITE 2-4B, Princeton, NJ, 08540
- Phone: (609) 380-3310
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1624663

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 15, 2015 | New notice | $6,500,000 | $6,500,000 | $0 | 1 | Dec 1, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624663/000114036115044601/0001140361-15-044601-index.htm) |
| May 27, 2015 | Amendment | $30,668,000 | $30,668,000 | $0 | 10 | Nov 3, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624663/000162466315000003/0001624663-15-000003-index.htm) |
| Feb 4, 2015 | Amendment | $30,000,000 | $30,000,000 | $0 | 3 | Nov 3, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624663/000162466315000002/0001624663-15-000002-index.htm) |
| Nov 13, 2014 | New notice | $30,000,000 | $21,275,000 | $8,725,000 | 2 | Nov 3, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624663/000162466314000001/0001624663-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard W. Van Duyne | Director |  |
| Venkatachalam Krishnan | Executive Officer, Director |  |
| James Gale | Director |  |
| Carol S. Ben-Maimon | Director |  |
| David W. Goodman | Director |  |
| Lavesh W. Samtani | Executive Officer |  |
| Gaurav W. Mehrotra | Executive Officer |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Dec 14, 2015](https://specstream.ai/data/form-d/week/2015-12-14) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Bionpharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).